MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson’s disease

I. Huertas Fernandez, S. Jesus, F.J. Garcia Gomez, J.A. Lojo, I. Bernal Bernal, M. Bonilla Toribio, J.F. Martin Rodriguez, D. Garcia Solis, P. Gomez Garre, P. Mir (Sevilla, Spain)

Meeting: 2016 International Congress

Abstract Number: 1392

Keywords: Dementia, Parkinsonism, Single-photon emission computed tomography(SPECT)

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Cognition

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate the role of APOE, MAPT, COMT, SNCA and GBA genes in both striatal dopaminergic denervation and the development of dementia in Parkinson’s disease (PD).

Background: The dual syndrome hypothesis for cognitive impairment in PD was recently proposed, establishing a dichotomy between a frontrostriatal dopamine-mediated syndrome, which leads to executive deficits, and a posterior cortical syndrome, which leads to dementia. Certain genes have been linked to cognitive decline in PD, and the exact contribution of these genes to each syndrome is still a matter of debate.

Methods: We genotyped APOE (rs429358 and rs7412), MAPT (rs9468), COMT (rs4680) and SNCA (rs356219) risk polymorphisms and sequenced GBA in a cohort of 298 PD patients. [123I]FP-CIT SPECTs from these patients were collected and the percentage of age-expected ligand uptake in putamen and caudate were calculated. The association between imaging and genetic parameters was investigated through linear regression with PLINK. A long-term review (mean disease duration 11 years) was performed to ascertain the presence and onset of dementia based on established criteria, and its relationship with the genetic factors was studied by Cox regression survival analyses.

Results: We found that the APOE2 allele (Pput=0.002; Pcau=0.012), the minor allele ‘G’ in SNCA polymorphism (Pput=0.018; Pcau=0.006) and variants in GBA (Pput=0.029; Pcau=0.019) all had a detrimental effect on striatal [123I]FP-CIT uptake in PD. Conversely, Met/Met carriers in COMT polymorphism had increased caudate uptake (Pcau=0.026). Further, the development of dementia was influenced by the APOE4 allele (HR=1.85; P=0.04) and variants in GBA (HR=2.06; P=0.03). MAPT had no role in either striatal degeneration or dementia.

Conclusions: APOE2, SNCA, COMT and GBA influence frontostriatal dysfunction whereas APOE4 and GBA influence the development of dementia. This suggests that GBA may be related to both dopaminergic and non-dopaminergic mechanisms of degeneration. Our results appear to indicate that the dichotomy of the dual syndromes may be driven by a broad dichotomy in these genetic factors.

To cite this abstract in AMA style:

I. Huertas Fernandez, S. Jesus, F.J. Garcia Gomez, J.A. Lojo, I. Bernal Bernal, M. Bonilla Toribio, J.F. Martin Rodriguez, D. Garcia Solis, P. Gomez Garre, P. Mir. Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/genetic-factors-influencing-frontostriatal-dysfunction-and-the-development-of-dementia-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/genetic-factors-influencing-frontostriatal-dysfunction-and-the-development-of-dementia-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley